The Association Between Pri-Mir-34b/Crs4938723 Polymorphism and Risk of Hepatocellular Carcinoma in Egyptian Patients
Al-Azhar International Medical Journal · 31.07.2025 · 2025 (7) · 18-23
DOI: 10.21608/aimj.2025.446630 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al-Azhar International Medical Journal, online erschienen am 31.07.2025. Verfasst von Alyaa Sabry Abdelwahed und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abdelwahed, A. S., Allam, N. A. A., Gomaa, A. I. E., Aboelkheir, S. E., Ghanem, H. S. M., & Ibrahim, N. H. (2025). The Association Between Pri-Mir-34b/Crs4938723 Polymorphism and Risk of Hepatocellular Carcinoma in Egyptian Patients. Al-Azhar International Medical Journal, 2025(7), 18-23. https://doi.org/10.21608/aimj.2025.446630
Vancouver
Abdelwahed AS, Allam NAA, Gomaa AIE, Aboelkheir SE, Ghanem HSM, Ibrahim NH. The Association Between Pri-Mir-34b/Crs4938723 Polymorphism and Risk of Hepatocellular Carcinoma in Egyptian Patients. Al-Azhar International Medical Journal. 2025;2025(7):18-23. doi:10.21608/aimj.2025.446630
BibTeX
@article{Abdelwahed2025,
author = {Abdelwahed, Alyaa Sabry and Allam, Naglaa Allam Ahmed and Gomaa, Asmaa Ibrahim Elsayed and Aboelkheir, Sameera Ezzat and Ghanem, Heba Samy Mohamed and Ibrahim, Nehal Hamdi},
title = {The Association Between Pri-Mir-34b/Crs4938723 Polymorphism and Risk of Hepatocellular Carcinoma in Egyptian Patients},
journal = {Al-Azhar International Medical Journal},
year = {2025},
volume = {2025},
number = {7},
pages = {18--23},
doi = {10.21608/aimj.2025.446630}
}
EUVIMED